The aryl hydrocarbon receptor (AhR) is a heterodimeric transcriptional regulator with pleiotropic functions in xenobiotic metabolism and detoxification, vascular development and cancer. Herein, we report a previously undescribed role for the AhR signalling pathway in the pathogenesis of the wet, neovascular subtype of age-related macular degeneration (AMD), the leading cause of vision loss in the elderly in the Western world. Comparative analysis of gene expression profiles of aged AhR −/− and wild-type (wt) mice, using high-throughput RNA sequencing, revealed differential modulation of genes belonging to several AMD-related pathogenic pathways, including inflammation, angiogenesis and extracellular matrix regulation. To investigate AhR regulation of these pathways in wet AMD, we experimentally induced choroidal neovascular lesions in AhR −/− mice and found that they measured significantly larger in area and volume compared to age-matched wt mice. Furthermore, these lesions displayed a higher number of ionized calcium-binding adaptor molecule 1-positive (Iba1 + ) microglial cells and a greater amount of collagen type IV deposition, events also seen in human wet AMD pathology specimens. Consistent with our in vivo observations, AhR knock-down was sufficient to increase choroidal endothelial cell migration and tube formation in vitro. Moreover, AhR knock-down caused an increase in collagen type IV production and secretion in both retinal pigment epithelial (RPE) and choroidal endothelial cell cultures, increased expression of angiogenic and inflammatory molecules, including vascular endothelial growth factor A (VEGFA) and chemokine (C-C motif) ligand 2 (CCL2) in RPE cells, and increased expression of secreted phosphoprotein 1 (SPP1) and transforming growth factor-1 (TGF 1) in choroidal endothelial cells. Collectively, our findings identify AhR as a regulator of multiple pathogenic pathways in experimentally induced choroidal neovascularization, findings that are consistent with a possible role of AhR in wet AMD.
Introduction
Age-related macular degeneration (AMD) is the leading cause of vision loss in the elderly in the Western world [1] [2] [3] . The late neovascular subtype, occurring in approximately 10% of patients, is responsible for severe visual impairment and is characterized by the growth of blood vessels from the choroid through Bruch's membrane, resulting in choroidal neovascularization (CNV). The visual decline observed in these patients as a result of CNV can be attributed in part to aberrant neovascularization, vasculogenesis/angiogenesis and, in part, to fibrosis [4] [5] [6] . Current treatments target leakage of vessels but are ineffective in treating fibrosis [4, 7, 8] . Therefore, identification of pathogenic mechanisms involved in all aspects of neovascularization is a critical step in developing more successful therapies. Multiple genetic and environmental risk factors for AMD have been identified to date [9] [10] [11] , which, independently or in combination, may lead to pathological changes in the structural integrity and function of retinal pigment epithelial (RPE) and choroidal endothelial cells, the cells compromised in CNV formation. Although the specific signalling pathways and biomolecular events which cause cellular dysfunction in AMD are not well understood, RNA transcriptome analysis of eyes from human AMD donors suggest that diverse pathogenic pathways, including angiogenesis, extracellular matrix (ECM) remodelling, inflammation and the immune response, are perturbed in RPE cells [12, 13] . This fact, along with putative crosstalk between RPE cells and the immune and vascular axes, underscores the need to study RPE cells along with other cell types within the microenvironment, eg endothelial cells of the choriocapillaris and choroid, and immune cells including macrophages, when investigating potential pathogenic mechanisms of AMD.
The aryl hydrocarbon receptor (AhR) is a member of the bHLH/PAS (basic helix-loop-helix/PerArnt-Sim) family of heterodimeric transcriptional regulators. AhR is important in mediating cellular responses to a wide variety of environmental contaminants, including polycyclic aromatic hydrocarbons, constituents of cigarette smoke and by-products of industrial combustion and automobile exhausts [14] [15] [16] [17] . Functionally, AhR has been shown to play a critical role in vascular development, angiogenesis and cancer [18] [19] [20] [21] , and deficiency in its activity has been linked to peripheral vascular disease, atherosclerosis and tumour development [20] [21] [22] [23] . Recently, we found that dysfunction of the AhR signalling pathway in aged mice results in pathological features of dry AMD in vivo [24] . Moreover, we discovered that the activity of the receptor in human primary RPE cell lines decreases as a function of age, suggesting a potential age-related compromise in normal RPE cellular clearance mechanisms. This is interesting in light of other studies reporting decreased AhR expression as a function of age in multiple organs of mice, rats and rabbits [25] [26] [27] . Finally, we observed an age-related thinning of the choroidal vascular layers in mice harbouring the AhR null allele (AhR −/− ). These findings, along with the reported regulatory role of AhR in angiogenesis, led us to hypothesize that the AhR signalling pathway may regulate pathogenic processes of neovascular AMD. To test this hypothesis, we: (a) investigated the RNA profile of the RPE-choroid of AhR −/− mice; (b) evaluated the severity and morphology of experimentally-induced CNV lesions in AhR −/− mice; (3) examined the effect of AhR knock-down on endothelial cell proliferation and migration; and (d) measured the expression of angiogenic, inflammatory and ECM representative genes altered in human CNV, in RPE and choroidal endothelial cell culture models following AhR knock-down. The findings support the hypothesis that the AhR plays a role in regulating ECM deposition, immune cell recruitment and angiogenesis, events which constitute necessary steps in the pathogenesis of AMD.
Materials and methods

Animals
Mice used included AhR −/− mice (B6.129-AhR^tm1 Bra/J) [28] originally obtained from Jackson Laboratory (Bar Harbour, ME, USA), where they were bred for 10 generations to C57BL6 mice and an additional two generations to C57BL/6 J mice. At Duke University, within the Division of Laboratory Animal Resources, over the last several years they have been bred a minimum of six generations to the 6 J background. Additionally, the mice were screened for the confounding retinal degeneration 8 mutation and its absence was confirmed as previously described [24] . Our study protocol was approved by the Duke University Institutional Animal Care and Use Committee. All animal experiments were performed in accordance with the guidelines of the ARVO statement for the Use of Animals in Ophthalmic and Vision Research.
RNA sequencing (RNA-seq) and pathway generation analysis
Mouse RPE-choroid tissue mRNA libraries were prepared using a TruSeq kit (Illumina, San Diego, CA, USA) [29, 30] . RPE-choroid pooled from eyes (n = 2) was used for each library preparation. Three biological replicate libraries were made from 11-13 month-old AhR −/− and wt mice. Six murine eye libraries were run on two non-independent lanes of the Illumina HiSeq 2500 at the Duke Genome Sequencing and Analysis Core Facility, using 100 bp single-end sequencing. Following quality assessment (FastQC), reads were mapped onto to the University of California Santa Cruz mm10 mouse genome assembly, using TopHat 1.4.0 with Bowtie 0.12.5 alignment engine. Read counts/feature were calculated using HTSeq-count [31] , with intersection strict option and using a predefined annotation of known genes from the mm10 genome assembly. Differential transcript abundance was calculated with EdgeR [32, 33] , utilizing the exactTest procedure. Genes with fewer than one fragments/kilobase of exon/million fragments mapped (FPKM) in more than two samples out of a total of six were not used in differential expression calculations. Significance was defined based on Benjamini-Hochberg false discovery rate (FDR) q values at 0.05 levels. Functional annotation, over-representation analysis and pathway analysis were performed using the GeneGo Metacore pathways software (MetaCore™ v 6.18, build 65505, Thomson Reuters, New York, NY, USA), based on the list of differentially regulated genes produced by EdgeR. False discovery rate was controlled by FDR procedure. The gene ontology (GO) biological process database was used to evaluate functional enrichment.
Mouse model of CNV
Laser photocoagulation was performed in cohorts of young and old wt and AhR −/− mice (4 months old, n = 8/genotype; and 11-13 months old, n = 20/ genotype), as previously described [34] . Briefly, four thermal burns were induced in each eye around the optic nerve, using a slit lamp delivery system. The mice were euthanized 3 weeks after laser treatment and the eyes were harvested for visualization of laser-induced CNV in posterior pole flat-mounts, or cryopreserved for immunohistochemistry and morphology experiments, as described in Supplementary materials and methods (see supplementary material). CNV lesion volume, area and size were measured in flat-mounts stained with propidium iodide to evaluate cellularity, or isolectin GS-IB 4 to examine vascularity, of the neovascular lesion, as described in Supplementary materials and methods.
Cell culture, siRNA transfection and functional assays Cell lines obtained from ATCC (Manassas, VA, USA) included RF/6A cells, a spontaneously transformed choroidal endothelial cell line derived from the eyes of a rhesus macaque fetus, passages [35] [36] [37] [38] [39] [40] , and ARPE19 cells, a spontaneously arising human RPE cell line derived from the eyes of a 19 year-old male donor, passages [21] [22] [23] [24] [25] [26] [27] [28] . Primary cell cultures used included RPE cells (1 ∘ RPE) isolated from donor eyes older than 60 years, collected from the North Carolina Organ Donor and Eye Bank Inc. < 6 h post-mortem and cultured within 24 h in accordance with the Declaration of Helsinki for research involving human tissue, as previously described [24] . Small interfering RNAs (siRNAs) were used to knock down AhR in cultures of ARPE19, 1 ∘ RPE and RF/6A endothelial cells for cell proliferation and viability assays, scrape wound migration assays (MEM 1% CS-FBS), tube formation assays (MEM 1% FBS) and AhR activity assays (7.5% CS-FBS), as described in Supplementary materials and methods (see supplementary material). RNA and protein were extracted at the indicated time points for quantitative real-time PCR (qPCR) and western blot assays. Primer sequences, list of antibodies and dilutions used are provided in Tables S1 and S2 (see supplementary material).
Statistical analysis and data collection
Statistical methods for data analysis other than the RNA-seq experiment included two-tailed Student's t-test and two-way ANOVA, with Sidak's multiple comparison test using GraphPad Prism. Values were considered statistically significant at p < 0.05. Each in vitro experiment was repeated a minimum of three times. Western blots, migration and tube-formation assays shown are representative of a minimum of three independent experiments.
Results
Transcriptomic analysis reveals AhR contributions to multiple AMD-related pathways
RNA-seq revealed 392 transcripts differentially expressed between RPE-choroid tissues isolated from aged wt and AhR −/− mouse eyes. The general distribution of differential gene expression as a function of transcript abundance (M-A plot) is shown in Figure 1A . Annotation performed using MetaCore (Thomson Reuters) pathway software, in conjunction with over-representation analysis of GO terms, highlighted the enrichment of genes in several functional categories (see supplementary material, Table S5 ). Among these, we focused on GO terms: (a) 'Extracellular matrix organization', GO:0030198 (FDR p value 3.137 × 10 −6 , 26 of 420 genes present in the list); (b) 'Inflammatory response', GO:0006954 (FDR p value 3.577 × 10 −6 , 32 of 610 genes); and (c) 'Angiogenesis', GO:0001525 (FDR p value 5.757 × 10 −4 , 20 of 394 genes). We cross-validated the RNA-seq data from each functional category in AhR −/− and wt mouse RPE-choroid samples using qPCR ( Figure 1B) ; primers are listed in Table S3 (see supplementary material). We observed down-regulation of Gpr124, a regulator of angiogenesis also known as tumour endothelial factor 5 [35, 36] , down-regulation of the ECM gene collagen type V α1 (Col5a1) and up-regulation of the inflammatory gene chemokine (C-C motif) receptor 1 (Ccr1) [37, 38] . These genes displayed a significant fold change, the direction and magnitude of which was consistent with the RNA-seq analysis.
AhR
−/− mice develop large CNV lesions compared to age-matched wild-type mice Figure 2C ; normalized to wt, p < 0.001). Measurements of CNV lesion thickness and volume determined from z-stacks and three-dimensional (3D) reconstruction of images spanning the lesion confirmed a significantly larger lesion volume in AhR −/− mice versus wt controls. (Figure 2D , E; normalized to wt, p < 0.0001, p < 0.05; see also supplementary material, Figure S2 ). Furthermore, vascularity as visualized in flat-mounts stained with isolectin GS-IB 4 confirmed an AhR-dependent increase in the laser-induced vascular lesion and vessel sprouting (Figure 2Avi, xii) . Finally, to determine whether neovascular lesion exacerbation is a result of AhR knock-out or a consequence of age, we examined CNV cellularity and vascularity in eyes of 4 month-old AhR −/− and wt mice (n = 8/cohort; Figure 3A ) and found a significant increase in lesion AhR signalling pathway is active in ARPE19 and RF6A choroidal endothelial cell lines Both the RPE and endothelial cells of the choriocapillaries and choroid play a role in CNV formation [8, 34] . Previously, we have shown that the AhR signalling pathway is active in human RPE cells [24] . Here, we investigated the AhR signalling pathway in choroidal endothelial cells by determining the expression and activity of the receptor in vitro, using RF/6A cells. AhR and its obligate binding partner AhR nuclear translocator (ARNT) were found to be expressed in both RF/6A cells and excised human choroid specimens ( Figure 4A ). Following validation of the efficiency of RNA and protein knock-down using three different siAhRs in endothelial cells at 48 AhR loss results in increased endothelial migration and tube formation A key process in neovascularization is cellular organization, which involves endothelial cell migration and sprouting, leading to the formation of an endothelial network [39] . To investigate the effect of AhR expression on choroidal endothelial cell migration, a scrape-wound assay was performed on RF/6A cells ( Figure 5A) . A significantly greater number of cells migrating into the wound were found following knock-down ( Figure 5B ; p < 0.0001). We also determined the effect of AhR loss on the ability of endothelial cells to re-organize and form a 3D network, indicative of vascular morphogenesis ( Figure 5C ). Total tube lengths were significantly longer in cells transfected with siRNAs targeting the AhR compared with control ( Figure 5D ; p < 0.0001). Suramin served as an additional control, inhibiting tube formation ( Figure 5C ). Cell viability and proliferation assays showed no significant differences between siCand siAhR-transfected RF/6A cells (see supplementary material, Figure S4 ), or treatment with conditioned media following AhR knock-down (see supplementary material, Figure S5 ), indicating that the increase in migration and tube formation is not due to a change in cell viability or proliferation. Cumulatively, these results suggest that the loss of AhR expression and/or activity may drive endothelial cells towards a pro-angiogenic phenotype.
AhR loss results in increased expression of inflammatory and angiogenic markers
Inflammation has been shown to play a central role in AMD pathogenesis, as activated microglial cells have been detected in the subretinal space of AMD patients [40] . Microglia are normally excluded from the outer retina, due to the presence of immunosuppressive factors secreted by RPE cells [41] [42] [43] [44] . In advanced age and following photoreceptor injury, retinal microglia migrate and accumulate within the outer retina [40] [41] [42] 45] and the neovascular lesion [46] . It is of significance, therefore, that we found an increased number of Iba1 + ( Figure 6A ) and macrophage chemotactic factor secreted phosphoprotein 1 (SPP1; see supplementary material, Figure S6A )-positive cells within the CNV lesions after laser-induced injury in AhR −/− mice compared to wt mice ( Figure 6B ; see also supplementary material, Figure S6B ; p < 0.001 and p < 0.01). Notably, we have also detected Iba1 + cells subretinally in aged AhR −/− in the absence of laser-induced CNV ( Figure 6A ). Since RPE and choroidal endothelial cells are involved in modulating the microenvironment of the outer retina secondary to the production and secretion of various cytokines and growth factors, we evaluated the impact of AhR loss on the expression of immunomodulatory and inflammatory cytokines/growth factors in ARPE19 and RF/6A cells. A significant increase in expression of chemokine (C-C motif) ligand 2 (CCL2) mRNA, important in microglial and macrophage recruitment, and vascular endothelial growth factor A (VEGFA) mRNA in ARPE19 cells, was found following AhR knock-down ( Figure 6C ; AhR p < 0.0001, VEGFA p < 0.01, CCL2 p < 0.0001). In RF/6A cells we observed an increase in transforming growth factor-β1 (TGFB1) mRNA levels, which may contribute to subretinal fibrosis [47] , an up-regulation of SPP1 and down-regulation of the anti-angiogenic factor, SERPINF1 ( Figure 6D ; AhR p < 0.01, TGFB1 p < 0.001, SPP1 p < 0.001, SERPINF1 p < 0.05) [48, 49] .
AhR loss results in increased expression of collagen
Impaired regulation of ECM turnover is a proposed AMD pathogenic mechanism [4, 50] . Further, the ECM molecule, COL4, is a component of sub-RPE deposits and CNV membranes [51, 52] . ECM turnover is also regulated in part by AhR in the liver, heart and kidneys [18, 53, 54] . Recently, we showed that COL4 is a component of the sub-RPE deposits that accumulate in aged AhR −/− mouse eyes, and demonstrated increased secretion of this protein from ARPE19 and primary human RPE cells following AhR knock-down in vitro [24] . With this in mind, and given that sub-RPE deposits, including drusen, are risk factors for the development of CNV, we assessed COL4 deposition and RF/6A cells ( Figure 7D ; p < 0.0001). Finally, to distinguish between COL4 associated with vascular basement membrane versus the extracellular matrix of the CNV lesion, we examined the immunolocalization pattern of the blood vessel markers smooth muscle protein 22α (transgelin-TAGLN) and α-smooth muscle actin (ACTA2) within CNV lesions of AhR
and wt mice (see supplementary material, Figure S7 ). No genotype-specific differences in the staining pattern were seen, supporting the finding that increased COL4 is a not a consequence of an increase in the number of vessels and/or associated vascular basement membranes.
Discussion
AhR expression and activity not only sustains important cellular functions, such as cell proliferation, differentiation and migration, but also maintains vascular homeostasis and angiogenesis [55] [56] [57] [58] [59] [60] . In this study, using in vitro and in vivo models in which AhR expression and activity was altered, we investigated the potential role of this receptor in the biology of wet AMD. We show that AhR regulates: (a) multiple pathways involved in the pathogenesis of wet AMD; and (b) the formation and severity of neovascular lesions in an animal model of CNV. Further, AhR knock-down increases the ability of endothelial cells to migrate and form tube-like structures in a 3D matrix in vitro, an activity that results in an alteration of the RPE-choroid microenvironment. Taking into account the results from previous studies demonstrating that AhR activity decreases as a function of age [24] [25] [26] [27] , our findings support the hypothesis that targeting the AhR signalling pathway may be a viable approach to developing potential therapies to treat wet AMD patients. The observation that AhR knock-out exacerbates CNV lesions in a murine model of wet AMD is novel, and verifies that the AhR plays an important role in maintaining both the RPE and the choroidal architecture and their responses to laser-induced injury. In some respects this is not surprising, as AhR-null mice develop increased ischaemia-induced angiogenesis compared to wt mice [61] , as well as cardiac hypertrophy consequent to coronary neovascularization, concomitant with increased VEGFA and hypoxia-inducible factor 1α expression in the heart [62, 63] . However, multiple studies have shown that AhR-null mice have hepatic vascular defects, impaired angiogenesis, decreased cell proliferation and migration that can compromise tumour xenograft growth [62, [64] [65] [66] [67] . This differential effect of AhR, resulting in pro-or anti-angiogenesis, may be cell type-and tissue-dependent [64] . In fact, in our cohort of AhR −/− mice, RNA expression and qPCR validation revealed a significant down-regulation of Gpr124, an orphan seven-pass transmembrane receptor, * p < 0.05, ** p < 0.001, *** p < 0.0001); siC, control siRNA; siAhR5, AhR siRNA; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; ns, not significant which has been shown to up-regulate VEGFA expression [36] . The severity of the neovascular lesions can be further explained by examining both the effect of AhR knock-down on RPE and choroidal endothelial cell phenotypes, as well as increased expression of pro-angiogenic factors. We found that AhR knock-down in ARPE19 cells did not affect cell migration (data not shown) but resulted in an increase in VEGFA expression. In contrast, RF/6A endothelial cells responded to AhR knock-down by an increase in their ability to migrate and morph into tube-like structures when plated in a 3D matrix.
Another AMD-relevant pro-angiogenic modulator is CCL2. This angiogenic chemokine is a critical regulator of migration of monocytes and macrophages and has also been shown to mediate TGFβ-induced angiogenesis [68] . In the eye, it has been reported to be up-regulated in aged mouse retinas [41, 42] , in RPE in AMD eyes [69] and in the aqueous humor of CNV patients [70] . The larger lesions observed in our cohort of AhR −/− mice could be due in part to an increased number of Iba1 + microglial cells localized within the lesion subsequent to up-regulation of CCL2 in ARPE19 cells, in concert with increased SPP1 and TGFB1 expression in RF/6A cells. Collectively, these observations support the postulate that AhR dysfunction exacerbates an already pro-angiogenic environment. Our findings may appear to contradict studies that have shown that AhR agonists also stimulate CCL2 expression in human umbilical cord vein endothelial cells [71, 72] . However, this is not surprising, considering the vital role of the AhR in clearance and the fundamental phagocytic responsibility of macrophages. The inflammatory status of the macrophages recruited within the lesions, critical to their overall function [73, 74] , remains to be determined.
A role for AhR in ECM remodelling has already been established; AhR knock-out mice develop liver fibrosis concomitant with an increase in TGFB1 and collagen expression [75, 76] . Consistent with these reports, we also observed increased production and deposition of the ECM molecule COL4. Specifically, AhR −/− mice displayed greater COL4 deposition in the CNV lesions compared to wt mice. In addition, we measured increased COL4 synthesis and secretion in both ARPE19 and RF/6A cells following AhR knock-down, supporting the role of the AhR signalling pathway in mediating matrix metabolism and deposition. ECM molecules, including COL4, are of great importance in the pathobiology of AMD, as they are abundant not only within sub-RPE deposits, which increase the risk for progression to wet AMD, but also within excised CNV membranes themselves [77] . Although the precise link between collagen and CNV formation is not known, it has been shown in the context of vascular biology to modulate angiogenesis, promoting vascular elongation, proliferation, stabilization and survival [78, 79] . Another ECM regulatory molecule important in AMD is MMP2, whose activity is reportedly disrupted in Bruch's membrane isolated from human AMD donor eyes [80] . We observed a down-regulation of MMP2 expression in ARPE19 and RF/6A cells with AhR knock-down. It should be noted that, although a decrease in COL1A1 expression was detected in our RNA-seq data, we were not able to confirm this expression change in the RPE and endothelial cell culture lines. This may not be surprising, given that we are comparing results obtained from expression studies on a complex multicellular tissue (RPE-choroid) harvested from an aged mouse to those from individual RPE or endothelial cell culture lines. Overall, our findings strengthen the hypothesis that AhR-mediated regulation of MMPs may contribute to impaired matrix degradation of Bruch's membrane and ultimately exacerbate pathology associated with AMD.
In summary, we found that decreased expression and activity of the AhR exacerbates murine neovascular AMD and increases cell migration and tube formation. The mechanism involves multiple AMD-related pathogenic pathways, including increased expression of pro-angiogenic mediators and altered matrix degradation. Our results suggest that the AhR may be important in the regulation of pathways of pathological importance in AMD. Future studies will focus on investigating the therapeutic benefits of targeting the AhR signalling pathway as a means of treating angiogenesis and fibrosis in wet AMD.
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